Literature DB >> 35676438

Seasonal residual activity in adult familial Mediterranean fever: a longitudinal observational study.

Sevtap Acer Kasman1, Mehmet Tuncay Duruöz2.   

Abstract

Although it is assumed that cold exposure triggers inflammation in patients with familial Mediterranean fever (FMF), seasonal differences in FMF have not yet been investigated. This study aims to investigate the association of seasonal changes with the frequency of attacks, disease severity, and subclinical inflammation in FMF. This longitudinal study examined adult patients with FMF on an established treatment followed up for at least 1 year in Istanbul. Clinical characteristics, medications, intraseasonal attacks counts, arthralgia and arthritis, disease severity, and the subclinical inflammation parameters were recorded covering four seasons. Friedman's and Cochran's Q tests were used to analyze changes in the above-mentioned data over seasons. Additionally, all attacks experienced in each season were added, and interseasonal differences were compared with the Chi-square goodness-of-fit test. Data for 240 observations (60 patients) were analyzed. The mean age and disease duration were 39.78 (SD 11.91) and 10 (IQR 6-22.75) years, respectively. The comparison of medians for four seasons did not show any statistical differences in terms of attack frequency, disease severity parameters, markers of subclinical inflammation, and the presence of arthralgia and arthritis. The total number of intraseasonal attacks experienced by patients differed among the seasons (p = 0.023), with a higher count in winter. Adult individuals with established FMF are more likely to experience attacks in winter than summer, but this difference may not be seen in the general parameters of disease activity/severity. This result supports the notion that there is a pronounced residual activity in winter.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arthritis; Climate; Cold temperature; Familial Mediterranean fever; Seasons

Mesh:

Substances:

Year:  2022        PMID: 35676438     DOI: 10.1007/s00296-022-05156-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  33 in total

1.  A fever gene comes in from the cold.

Authors:  D L Kastner; J J O'Shea
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

2.  The factors considered as trigger for the attacks in patients with familial Mediterranean fever.

Authors:  Omer Karadag; Abdurrahman Tufan; Veli Yazisiz; Kemal Ureten; Sedat Yilmaz; Muhammet Cinar; Ali Akdogan; Hakan Erdem; Mehmet Akif Ozturk; Salih Pay; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2012-07-20       Impact factor: 2.631

Review 3.  Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity.

Authors:  Abdulla Watad; Shir Azrielant; Nicola Luigi Bragazzi; Kassem Sharif; Paula David; Itay Katz; Gali Aljadeff; Mariana Quaresma; Galya Tanay; Mohammad Adawi; Howard Amital; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2017-06-16       Impact factor: 7.094

Review 4.  Familial Mediterranean fever.

Authors:  Fatos Onen
Journal:  Rheumatol Int       Date:  2005-11-10       Impact factor: 2.631

5.  Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients.

Authors:  D J Hawley; F Wolfe; F A Lue; H Moldofsky
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

6.  EULAR recommendations for the management of familial Mediterranean fever.

Authors:  Seza Ozen; Erkan Demirkaya; Burak Erer; Avi Livneh; Eldad Ben-Chetrit; Gabriella Giancane; Huri Ozdogan; Illana Abu; Marco Gattorno; Philip N Hawkins; Sezin Yuce; Tilmann Kallinich; Yelda Bilginer; Daniel Kastner; Loreto Carmona
Journal:  Ann Rheum Dis       Date:  2016-01-22       Impact factor: 19.103

7.  Current trends in colchicine treatment in familial Mediterranean fever.

Authors:  Micaela La Regina; Eldad Ben-Chetrit; Armen Yuri Gasparyan; Avi Livneh; Huri Ozdogan; Raffaele Manna
Journal:  Clin Exp Rheumatol       Date:  2013-09-09       Impact factor: 4.473

8.  IL-1 blockers together with colchicine may be administered as first line therapy in familial Mediterranean fever with amyloidosis.

Authors:  Mehmet Engin Tezcan
Journal:  Med Hypotheses       Date:  2019-06-10       Impact factor: 1.538

9.  Cold Exposure Related Fever with an Mediterranean Fever (MEFV) Gene Mutation.

Authors:  Shima Kumei; Tsukasa Nozu; Masumi Ohira; Saori Miyagishi; Toshikatsu Okumura
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

10.  Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis.

Authors:  Hiroaki Mori; Tetsuji Sawada; Susumu Nishiyama; Kota Shimada; Koichiro Tahara; Haeru Hayashi; Eri Kato; Mayu Tago; Toshihiro Matsui; Shigeto Tohma
Journal:  BMC Musculoskelet Disord       Date:  2019-01-18       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.